Seminal pharmaceutical trials: maintaining masking in analysis.
Boers
Maarten
M
Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, 1007 MB Amsterdam, Netherlands. keb.info@vumc.nl
D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004345:Drug Industry; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D013223:Statistics as Topic / Q000379:methods*; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib